Literature DB >> 9345665

Family history and risk of fatal prostate cancer.

C Rodríguez1, E E Calle, H L Miracle-McMahill, L M Tatham, P A Wingo, M J Thun, C W Heath.   

Abstract

To examine the relation between fatal prostate cancer and family history of prostate cancer in a first-degree relative, we analyzed data from a prospective mortality study of 481,011 men with no history of cancer at enrollment in 1982. During 9 years of follow-up, 1,922 deaths from prostate cancer occurred. Results from Cox proportional hazard models showed that family history of prostate cancer was related to fatal prostate cancer [rate ratio (RR) = 1.60; 95% confidence interval (CI) = 1.31-1.97]; men with two or more affected relatives had a greater than threefold increase in risk (RR = 3.19; 95% CI = 1.51-6.71). Men whose relatives were diagnosed with prostate cancer before age 65 years (RR = 2.03; 95% CI = 1.33-3.09) had a greater effect of family history than men whose relatives were diagnosed at older ages (RR = 1.50; 95% CI = 1.17-1.91). Rate ratios did not increase with decreasing age of the study participants. The 60% increase in risk for men with at least one affected relative is lower than that reported in previous studies.

Entities:  

Mesh:

Year:  1997        PMID: 9345665     DOI: 10.1097/00001648-199710000-00007

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  28 in total

1.  APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis.

Authors:  Ya-Nan Ji; Ping Zhan; Jing Wang; Li-Xin Qiu; Li-Ke Yu
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

2.  Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer.

Authors:  Dong Lu; Xiaodan Yu; Yukai Du
Journal:  Mol Biol Rep       Date:  2010-11-13       Impact factor: 2.316

3.  MGMT Leu84Phe gene polymorphism and lung cancer risk: a meta-analysis.

Authors:  Zhi-xiong Qiu; Fei Xue; Xuan-feng Shi; Xiao He; Hui-ni Ma; Lan Chen; Pin-zhong Chen
Journal:  Tumour Biol       Date:  2014-01-05

4.  The association of APE1 Asp148Glu gene polymorphisms and lung cancer risk: an updated meta-analysis.

Authors:  Wen Chen; Qin Wang; Mang Liu; Xiao-bing Ding
Journal:  Tumour Biol       Date:  2013-12-06

5.  XPA A23G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Ji-Hong Zou; Li An; Shi Chen; Li-Qun Ren
Journal:  Mol Biol Rep       Date:  2011-05-25       Impact factor: 2.316

6.  Identification of genetic risk associated with prostate cancer using ancestry informative markers.

Authors:  L J Ricks-Santi; V Apprey; T Mason; B Wilson; M Abbas; W Hernandez; S Hooker; M Doura; G Bonney; G Dunston; R Kittles; C Ahaghotu
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-07-17       Impact factor: 5.554

7.  p53 Pro72Arg polymorphism and prostate cancer in men of African descent.

Authors:  L Ricks-Santi; T Mason; V Apprey; C Ahaghotu; A McLauchlin; D Josey; G Bonney; G M Dunston
Journal:  Prostate       Date:  2010-12-01       Impact factor: 4.104

8.  GSTP1 Ile105Val polymorphism is associated with lung cancer risk among Asian population and smokers: an updated meta-analysis.

Authors:  Chun-hua Xu; Qin Wang; Ping Zhan; Qian Qian; Li-Ke Yu
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

9.  The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.

Authors:  Li-Xin Qiu; Ru-Tian Li; Jian-Bing Zhang; Wen-Zhao Zhong; Jian-Ling Bai; Bao-Rui Liu; Ming-Hua Zheng; Xiao-Ping Qian
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

10.  Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy.

Authors:  Mark Thalgott; Martina Kron; Johannes M Brath; Donna P Ankerst; Ian M Thompson; Juergen E Gschwend; Kathleen Herkommer
Journal:  World J Urol       Date:  2017-11-21       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.